People
Mark Holodniy
Professor of Medicine, Stanford University School of Medicine and Stanford Health Policy Associate
AIDS Research Center
VA Palo Alto Health Care System
3801 Miranda Ave. (132)
Palo Alto, California 94304-5107
View Mark Holodniy's bio, list of research, recent publications and events »
View Mark Holodniy's publications as a single, printable list »
Records 1-11 of 14Sort by Title | Year
- A Systematic Review of Cost-Utility Analyses in HIV/AIDS
Hornberger J, Mark Holodniy, Robertus K, Winnike M, Gibson M, Verhulst E
Medical Decision Making vol. 27 (2007)
- Cost Effectiveness of HIV Screening in the Elderly
Gillian D. Sanders, Bayoumi AM, Mark Holodniy, Douglas K. Owens
Ann Intern Med vol. 148 (2008)
- Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users
Cipriano, L.E., Zaric, G.S., Mark Holodniy, Eran Bendavid, Douglas K. Owens, Margaret L. Brandeau
PLoS One vol. 7 (2012)
- Determinants of the cost of health services used by veterans with HIV
Barnett PG, Chow A, Vilija Joyce, Bayoumi AM, Griffin SC, Nosyk B, Mark Holodniy, Brown ST, Sculpher M, Anis AH, Douglas K. Owens
Medical Care vol. 49, 9 (2011)
Effect of Treatment Interruption and Intensification of Antiretroviral Therapy on Health-related Quality of Life in Patients with Advanced HIV
Vilija Joyce, Paul G. Barnett, Adam Chow, Ahmed M. Bayoumi, Susan C. Griffin, Huiying Sun, Mark Holodniy, Sheldon T. Brown, Tassos C. Kyriakides, D. William Cameron, Mike Youle, Mark Sculpher, Aslam H. Anis, Douglas K. Owens
Medical Decision Making (2011)
- Frequency of HIV Screening in the Veterans Health Administrations: Implications for Early Diagnosis of HIV Infection
Valdiserri R, Rodriguez F, Mark Holodniy
AIDS Education and Prevention vol. 20 (2008)
Health-related Quality of Life in a Randomized Trial of Antiretroviral Therapy for Advanced HIV Disease
Vilija Joyce, Paul G. Barnett, Bayoumi AM, Griffin SC, Kyriakides TC, Wei Yu, Vandana Sundaram, Mark Holodniy, Brown ST, Cameron W, Youle M, Sculpher M, Anis AH, Douglas K. Owens
Journal of Acquired Immune Deficiency Syndromes vol. 50, 1 (2009)
- New Protease Inhibitors for the Treatment of Chronic Hepatitis C: A Cost-Effectiveness Analysis
Shan Liu, Lauren E. Cipriano, Mark Holodniy, Douglas K. Owens, Jeremy Goldhaber-Fiebert
Annals of Internal Medicine vol. 156, 4 (2012)
- One-year outcomes of community-acquired and health care-associated pneumonia in the Veterans Affairs Health Care System
Hsu JL, Siroka AM, Mark W. Smith, Mark Holodniy, Meduri GU
International Journal of Infectious Disease vol. 15 (2011) - Quality of life of patients with advanced HIV/AIDS: measuring the impact of both AIDS-defining events and non-AIDS serious adverse events.
Anis AH, Nosyk B, Sun HSun H, Guh DPGuh DP, Bansback NBansback N, Li X, Paul G. Barnett, Vilija Joyce, Swanson KM, Kyriakides TC, Mark Holodniy, Cameron DW, Brown ST, OPTIMA TEAM
JAIDS vol. 51, 5 (2009) - Relationship between Antiretroviral Prescribing Patterns and Treatment Guidelines in Treatment-Naive, HIV-1 Infected U.S. Veterans
Mark Holodniy, Hornberg J, Rapoport D, Robertus K, MaCurdy TE, Lopez J, Volberding P, Deyton L
JAIDS vol. 44 (2007)


@FSIStanford
Stanford Global Gateway